Abstract
Combination effect of antitumor agents including carboquone was evaluated on the concept of pharmacological synergism and not therapeutic synergism in ascites sarcoma-180 system. Combinations of carboquone plus cyclophosphamide, doxorubicin, and Methotrexate in simultaneous administration and carboquone plus doxorubicin in alternate one provided synergism. Combination effect of agents was affected by the schedule of drug administration. Toxicity of carboquone in combination with many antitumor agents, generally, decreased in simultaneous administration. Approved agents in combination with carboquone in simultaneous administration were Mitomycin-C, daunorubicin, Actinomycin-d, vinblastine, vincristine, Ancytabine, and 6-mercaptopurine. Those in alternate administration were Actinomycin-D and vinblastine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
